Holen Sie sich die Stockscreener-App
1.09
1.94%
-0.0216
Schlusskurs vom Vortag:
$1.1116
Offen:
$1.11
24-Stunden-Volumen:
16,538
Relative Volume:
0.05
Marktkapitalisierung:
$7.27M
Einnahmen:
$5.64M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-2.0566
EPS:
-0.53
Netto-Cashflow:
$-22.36M
1W Leistung:
-6.84%
1M Leistung:
-6.84%
6M Leistung:
-32.30%
1J Leistung:
-85.77%
1-Tages-Spanne:
$1.06
$1.12
1-Wochen-Bereich:
$1.06
$1.20
52-Wochen-Spanne:
$0.95
$7.749
Evogene Ltd Stock (EVGN) Company Profile
Vergleichen Sie EVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.09 | 7.81M | 5.64M | -23.88M | -22.36M | -0.53 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-29 | Eingeleitet | Aegis Capital | Buy |
| 2020-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Eingeleitet | Oppenheimer | Outperform |
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery - Barchart.com
Evogene Ltd. Earnings Call: Balancing Growth and Challenges - TipRanks
Evogene Ltd (EVGN) Q1 2025 Earnings Call Highlights: Strategic Expense Reductions and Promising ... - Yahoo Finance
Evogene stock target cut to $3.50, maintains buy at Lake Street - Investing.com Nigeria
Evogene price target lowered to $3.50 from $5 at Lake Street - TipRanks
Evogene Ltd. (NASDAQ:EVGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Evogene: Q1 Earnings Snapshot - New Haven Register
Evogene Reports First Quarter 2025 Financial Results - Krishak Jagat
Evogene Ltd. Reports Q1 2025 Financial Results - TipRanks
Evogene earnings beat by $0.35, revenue fell short of estimates - Investing.com Australia
Evogene Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Evogene Reports Narrower Loss in Q1 2025 - Investing.com
Earnings call transcript: Evogene Reports Narrower Loss in Q1 2025 By Investing.com - Investing.com UK
Evogene Announces Q1 2025 Financial Results and Strategic Acquisition - TipRanks
Evogene Earnings: Revenue Drops to $2.4M While $15.25M ICL Deal Signals Major Strategic Shift - Stock Titan
Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene (EVGN) Projected to Post Quarterly Earnings on Wednesday - Defense World
Evogene Schedules First Quarter 2025 Financial Results Release - Krishak Jagat
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories - Barchart.com
Evogene Announces Pricing Of US$8,500,000 Registered Direct Offering - Barchart.com
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Defense World
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World
Biotech Alert: Searches spiking for these stocks today - TipRanks
Industry News: Minnesota Co-Op Names Next CEO, ICL Acquires Lavie Bio - thedailyscoop.com
Why Evogene Ltd. (EVGN) Soared on Monday - MSN
Stocks in Oversold Territory: EVGN, MLGO, PRSO, SHFSMore Undervalued Players Worth Watching Inside - openPR.com
10 Micro-, Small-Cap Companies Lead Monday’s Charge - Insider Monkey
ICL acquires Evogene subsidiary Lavie Bio By Investing.com - Investing.com South Africa
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio and MicroBoost AI - Benzinga
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AIEvogene (NASDAQ:EVGN) - Benzinga
Minerals Giant ICL to Acquire AI-Driven Ag Tech Company Lavie Bio - AgriBusiness Global
Evogene To Sell Majority Of Lavie Bio To ICL For Undisclosed Terms - Nasdaq
ICL acquires Evogene subsidiary Lavie Bio - Investing.com Australia
Evogene Announces Sale of Lavie Bio’s Assets to ICL - TipRanks
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio - Nasdaq
Evogene (NASDAQ:EVGN) Share Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World
Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com - Defense World
Evogene stock hits 52-week low at $0.99 amid market challenges By Investing.com - Investing.com South Africa
Evogene Schedules Third Quarter 2024 Financial Results Release - marketscreener.com
Evogene stock hits 52-week low at $0.99 amid market challenges - Investing.com Australia
Biomica CEO Set to Engage in Panel Discussion at 8th Annual Euro - GuruFocus
Evogene stock hits 52-week low at $1.18 amid market challenges - Investing.com Canada
Evogene stock hits 52-week low at $1.18 amid market challenges By Investing.com - Investing.com South Africa
Finanzdaten der Evogene Ltd-Aktie (EVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.89%
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):